— Know what they know.
Not Investment Advice

AIDA OTC

Aida Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +50.0% 3Y: -97.0% 5Y: -97.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $8101 mcap · 7M float · 0.028% daily turnover · Short 99% of daily vol

Income Trends

Revenue
$29M -1.5% ▼
3Y CAGR: +23.1%
Gross Profit
$15M -5.6% ▼
3Y CAGR: +10.1%
Operating Income
$5M +38.3% ▲
3Y CAGR: +24.0%
Net Income
$3M +88.4% ▲
3Y CAGR: +18.8%
EPS (Diluted)
$0.10 +66.7% ▲
3Y CAGR: +12.7%
EBITDA
$7M +21.7% ▲
3Y CAGR: +26.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2004FY2005FY2006FY2007
Revenue$16M$25M$30M$29M
YoY Growth+0.0%+56.8%+20.9%-1.5%
Cost of Revenue$5M$8M$14M$15M
Gross Profit$11M$16M$16M$15M
Gross Margin70.5%66.0%52.5%50.3%
R&D Expenses$263K$39K$325K$284K
SG&A Expenses$8M$14M$11M$9M
Operating Expenses$8M$14M$12M$9M
Operating Income$3M$2M$4M$5M
Operating Margin18.3%8.6%13.3%18.6%
Interest Expense$481K$1M$2M$2M
Income Before Tax$3M$2M$2M$2M
Tax Expense$151K$145K$173K$360K
Net Income$2M$1M$1M$3M
Net Margin10.5%6.0%4.9%9.4%
EPS (Diluted)$0.07$0.06$0.06$0.10
EBITDA$4M$4M$6M$7M
Shares Outstanding23M23M26M27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms